Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes

NCT01006291 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

687

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin degludec
DRUG: insulin degludec
DRUG: insulin glargine

Sponsor

Novo Nordisk A/S